Everytime its always happened. Just not this quick.

First 23 Last

Share
Profile

Follow
wop

2,296 Posts.

356

24/03/20

16:31

Post #: 43672711
Share

Originally posted by wop ↑

Hope your all having a good Friday. I thought i would start a new thread and i know that a lot would be asking themselves this question. What do i do here? I have to admit that no one really saw FDA saying not yet guys,need more info. That and Corona which i really did think would help our cause and it probably will still over the next few weeks.

But just want to give my take on whats going on here and if we can put the virus aside (as hard as that sounds) im looking at the facts in the RAP SP over 4.5 years

* July 2015c SP (Crap market like now just floated) 2c
* Aug 2017 (stuffed up US trails) 8c from a high of 55c
* Oct 2018 ( lower than expected results US mark 2 trails) 8c from a high of 28c
* March 2020 (FDA non approval) 8.5c from a high of 42c

Given we have what we all know in regards regulatory approvals for kids and adults in Europe and Asia Pacific along with Sleep App about to be filed soon and listening to Big Tony's conference call yesterday and well done to both BL for organising and Tony(keep up the good work mate) for fronting up again as tough as it was. We are on the door step of commercialization and revenue.

Each time when the shares have been at these levels i have bought and as i mentioned with a lot less going for the Co i have been presented with the opportunity to take a profit of 200 to 300% in a fairly short period of time.

Im not making any recommendations because we didnt have this virus and we dont know how its going to play out my guess is positive. But its something to consider over the weekend that will be full of doom and gloom.

Keep safe GLTAH.

Expand

Everytime its always happened. Just not this quick.

RAP Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

OPL

Opyl forms JV with UK and US consortium to bring products to the world

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

AAI

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies